Literature DB >> 10580352

Treatment of venous leg ulcers with sulodexide.

G Scondotto1, D Aloisi, P Ferrari, L Martini.   

Abstract

Venous ulcers are still today one of the main socioeconomic problems of medical interest in terms of prevalence, morbidity, and costs to the health service. In the past, various studies have been carried out to identify a systemic pharmacologic treatment able to accelerate venous ulcer healing times, but frequently the results have not been satisfactory. The aim of this study was to evaluate the efficacy of sulodexide, a drug with profibrinolytic and antithrombotic activity, in accelerating venous ulcer's healing time. Ninety-four patients (32 men and 62 women), aged 72 years old on average, were randomly distributed between two groups. In the first group ("control group") a standard treatment was applied, which consisted of cleansing by washing with physiological solution and the application of elastic compression with short-extensibility, removable bandages. The second group ("sulodexide group") received the standard treatment plus sulodexide (600 lipoprotein lipase releasing units [LRU] by im route per day for 30 consecutive days, followed by 500 LRU by oral route per day for a further 30 days). After 2 months the venous ulcers were found healed in 15 patients (36%) in the control group and in 30 patients (58%) in the sulodexide group (p = 0.03). The life table showed that the healing times were shorter in the sulodexide group in the first 2 months of treatment. Total healing times amounted to 110 days in the control group and 72 days in the sulodexide group (p = 0.08) and the results were in proportion to the initial severity of the lesion. A significant correlation was noted between ulcer healing times and severity of the initial ulcerous lesion, the duration of the ulcer, and the group the patient belonged to. No correlation was found between age, gender of the patient and the etiology of the ulcer. In conclusion sulodexide was shown effective in the treatment of venous leg ulcers, yielding healing more quickly than the standard treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580352     DOI: 10.1177/000331979905001102

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  15 in total

Review 1.  Management of venous leg ulcers.

Authors:  Deborah A Simon; Francis P Dix; Charles N McCollum
Journal:  BMJ       Date:  2004-06-05

2.  A large Italian observational multicentre study on vascular ulcers of the lower limbs (Studio Ulcere Vascolari).

Authors:  Alessandro Apollonio; Pier L Antignani; Michelangelo Di Salvo; Giacomo Failla; Giorgio Guarnera; Giovanni Mosti; Elia Ricci
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

Review 3.  Venous leg ulcers.

Authors:  E Andrea Nelson
Journal:  BMJ Clin Evid       Date:  2011-12-21

4.  Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors:  Ferdinando Mannello; Joseph D Raffetto
Journal:  Am J Transl Res       Date:  2010-11-23       Impact factor: 4.060

5.  Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway.

Authors:  Joseph D Raffetto; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-04-20       Impact factor: 5.858

Review 6.  Water for wound cleansing.

Authors:  Ritin Fernandez; Heidi L Green; Rhonda Griffiths; Ross A Atkinson; Laura J Ellwood
Journal:  Cochrane Database Syst Rev       Date:  2022-09-14

Review 7.  Venous leg ulcers.

Authors:  E Andrea Nelson; June Jones
Journal:  BMJ Clin Evid       Date:  2008-09-15

8.  Sulodexide Improves Contraction and Decreases Matrix Metalloproteinase-2 and -9 in Veins Under Prolonged Stretch.

Authors:  Joseph D Raffetto; Wentao Yu; Xi Wang; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2020-03       Impact factor: 3.271

9.  Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Vessel Plus       Date:  2021-05-29

Review 10.  Sulodexide for treating venous leg ulcers.

Authors:  Bin Wu; Jing Lu; Ming Yang; Ting Xu
Journal:  Cochrane Database Syst Rev       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.